US2004043972A1PendingUtilityA1

3-Methylene steroid derivatives

Priority: Nov 29, 1999Filed: Apr 28, 2003Published: Mar 4, 2004
Est. expiryNov 29, 2019(expired)· nominal 20-yr term from priority
A61P 37/02A61P 37/00A61P 29/00A61P 19/02A61P 19/00C07J 1/007C07J 1/0096C07J 71/001C07J 1/00
21
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention concerns a 3-methylene steroid derivative selected from the group consisting of (7α,17β)-7-methyl-3-methyleneestr-5(10)-en-17-ol, (5β,7α,17α)-5,10-epoxy-7-methyl-3-methylene-19-norpregn-20-yn-17-ol, (5β,7α,17β)-5,10-epoxy-7-methyl-3-methyleneestran-17-ol, (5α,7α,17α)-7-methyl-3-methylene-19-norpregn-20-en-17-ol, (5α,7α,17α)-7-methyl-3-methylene-19-norpregn-20-yn-17-ol, (5β,7α,17α)-7-methyl-3-methylene-19-norpregnan-17-ol, (7α)-7-methyl-3,17-dimethyleneestr-5(10)ene, (7α,16α,17β)-7,16-dimethyl-3-methylene-17-(1-propynyl)estr-5(10)-en-17-ol, (7α,16α,17β)-16-ethyl-7-methyl-3-methylene-17-(1-propynyl)estr-5(10)-en-17-ol, (7α,17β)-7-methyl-3-methylene-17-(1 -propynyl)estr-5(10)-en-17-ol, (7α,16β,17β)-16-ethyl-7-methyl-3-methylene-19-norpregn-5(10)-en-20-yn-17-ol, (7α)-3-methylene-7-methylestr-5(10)-ene, (7α)-3-methylene-7-methylestr-5(10)-en-17-one O-methyloxime and (7α)-3-methylene-7-methylestr-5(10)-en-17-one oxime.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A 3-methylene steroid derivative selected from the group consisting of (7α,17β)-7-methyl-3-methyleneestr-5(10)-en-17-ol, (5β,7α,17α)-5,10-epoxy-7-methyl-3-methylene-19-norpregn-20-yn-17-ol, (5β,7α,17β)-5,10-epoxy-7-methyl-3-methyleneestran-17-ol, (5α,7α,17α)-7-methyl-3-methylene-19-norpregn-20-en-17-ol, (5α,7α,17α)-7-methyl-3-methylene-19-norpregn-20-yn-17-ol, (5β,7α,17α) -7-methyl-3-methylene-19-norpregnan-17-ol, (7α)-7-methyl-3,17-dimethyleneestr-5(10) ene, (7α,16α,17β)-7,16-dimethyl-3-methylene-17-(1-propynyl)estr-5(10)-en-17-ol, (7α,16α,17β)-16-ethyl-7-methyl-3-methylene-17-(1-propynyl)estr-5(10)-en-17-ol, (7α,17β)-7-methyl-3-methylene-17-(1-propynyl)estr-5(10)-en-17-ol, (7α,16β,17β)-16-ethyl-7-methyl-3-methylene-19-norpregn-5(10)-en-20-yn-17-ol, (7α)-3-methylene-7-methylestr-5(10)-ene, (7α)-3-methylene-7-methylestr-5(10)-en-17-one O-methyloxime and (7α)-3-methylene-7-methylestr-5(10)-en-17-one oxime.  
     
     
         2 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (7α,17β)-7-methyl-3-methyleneestr-5(10)-en-17-ol.  
     
     
         3 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (5β,7α,17α)-5,10-epoxy-7-methyl-3-methylene-19-norpregn-20-yn-17-ol.  
     
     
         4 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (5β,7α,17α)-5,10-epoxy-7-methyl-3-methyleneestran-17-ol.  
     
     
         5 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (5α,7α,17α)-7-methyl-3-methylene-19-norpregn-20-en-17-ol.  
     
     
         6 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (5α,7α,17α)-7-methyl-3-methylene-19-norpregn-20-yn-17-ol.  
     
     
         7 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (5β,7α,17α)-7-methyl-3-methylene-19-norpregnan-17-ol.  
     
     
         8 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (7α)-7-methyl-3,17-dimethyleneestr-5(10)ene.  
     
     
         9 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (7α,16α,17β)-7,16-dimethyl-3-methylene-17-(1-propynyl)estr-5(10)-en-17-ol.  
     
     
         10 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (7α,16α,17β)-16-ethyl-7-methyl-3-methylene-17-(1-propynyl)estr-5(10)-en-17-ol.  
     
     
         11 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (7α,17β)-7-methyl-3-methylene-17-(1-propynyl)estr-5(10)-en-17-ol.  
     
     
         12 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (7α,16β,17β)-16-ethyl-7-methyl-3-methylene-19-norpregn-5(10)-en-20-yn-17-ol.  
     
     
         13 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (7α)-3-methylene-7-methylestr-5(10)-ene.  
     
     
         14 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (7α)-3-methylene-7-methylestr-5(10)-en-17-one O-methyloxime.  
     
     
         15 . The 3-methylene steroid derivative according to  claim 1 , wherein the 3-methylene steroid derivative is (7α-3-methylene -7-methylestr-5(10)-en-17-one oxime.

Join the waitlist — get patent alerts

Track US2004043972A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.